Related Experiment Video
Updated: Dec 2, 2025

Murine Model of CD40-activation of B cells
Published on: March 5, 2010
4-1BB (CD137) in anticancer chimeras
Ignacio Melero1,2,3,4, Pedro Berraondo1,2,3
1Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.
Abstract:
4-1BB (CD137, TNFRSF9) mediates costimulatory signals important for activation and persistence of cytotoxic T lymphocytes. In this issue of JEM, Oda et al. (https://doi.org/10.1084/jem.20191166) report on a chimeric construction encompassing extracellular Fas and intracellular 4-1BB to dramatically improve adoptive T cell therapy.
More Related Videos
08:04In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function
Published on: February 27, 2019
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025